Undervalued by 14%, this wide-moat company has turnaround potential.
The Czech Health Ministry said supply problems were caused by market panic after a major US producer's factory stopped ...
Baxter International has increased allocations for two U.S. IV solutions to 100% following the disruption caused by Hurricane Helene at its North Cove, N.C., facility, according to a letter to ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Elevance Health (NYSE: ELV) Q4 2024 Earnings Call Jan 23, 2025, 8:30 a.m. ET ...
The UK injectable drug delivery market is set to grow at 8.80% CAGR through 2034, driven by rising obesity rates and the approval of weight-loss injectable.
The Sterile Injectable Contract manufacturing market is expected to grow from an estimated USD 16.54 bn in 2024 to USD 34.77 bn in 2033, at a CAGR of 8.50%.
11hon MSN
Elevance Health Q3 2024 misses EPS estimates, stock rises ...
The global topical bioadhesives market currently stands at USD 392.5 Million in 2023 and it is further projected to expand at ...
Nothing lasts forever. All good things come to an end. Yesterday is history. Unless you’re talking about one of your favorite discontinued products, in which case no words have the power to take their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback